News


All series


All News

I wore glasses and contact lenses as a child, and my optometrist who I grew up with was very inspiring. He was the one who mentioned the profession to start with and guided me along the way. Now the fun thing is that I was able to reconnect with him just last year in a professional setting. He and I both do specialty contact lens work, so that was really fun.

Top 9 optometry memes

Optometrists have the best sense of humor. We say this from experience. Optometry Times is just one of many medical magazines in our parent company, and we have bragging rights with our fellow editors because we have the coolest doctors (although, we hear the urologists are a pretty good time).

If you think more allergy patients are landing in your chair every year, you’re absolutely correct. The prevalence of allergy is rising worldwide to near epidemic proportions and carries a significant burden for both the individual patient as well as healthcare systems globally.

Last week, a bill allowing New Jersey optometrists to avoid joining vision care plans died on the desk of Gov. Chris Christie (R-NJ) in a pocket veto. The bill would have given ODs in the state the ability to participate in third-party medical insurance plans without being required to join accompanying vision care plans as well.

Anyone who treats ocular surface disease (OSD) recognizes the important role oral antibiotics play in therapy, especially in patients with meibomian gland dysfunction (MGD). Yet the existing evidence is insufficient to conclude the effectiveness of oral antibiotic therapy, according to a report published in Ophthalmology.

Dry eye disease (DED) has long been thought to be a progressive condition, but a study published in Ophthalmology found that most of its participants who were diagnosed with DED reported no change or some level of improvement.

Bausch + Lomb, a Valeant Pharmaceuticals company, has acquired Alden Optical Laboratories. The acquisition is the latest in a series of moves by Bausch + Lomb that sent ripples through the gas permeable subset of the contact lens industry.

It’s an oft-repeated mantra among those of us who treat glaucoma: The goal of glaucoma therapy is to maintain adequate functional vision until the patient dies. Like a lot of mantras, we spout it almost glibly.

Nowadays, you are unlikely to read a journal or go to a meeting without hearing the importance of dry eye disease in our practices and for our surgical patients. This was not always the case. I want to introduce you to the Tear Film and Ocular Surface Society (TFOS) and the brains behind it: David Sullivan, PhD, and his family- Rose, Ben, and Amy-who dedicate their lives to help us better understand dry eye disease.

From new ways of predicting who will and won’t develop diabetes, to new diabetes meds, to new evidence regarding which anti-vascular endothelial growth factor (VEGF) might be better for your specific patient, the last year has given us better tools for helping our patients with diabetes.

It has been estimated that by the year 2020, there will be an increase in the number of Americans living with glaucoma from 60 to 80 million. Given that women outnumber and outlive men, this will result in a vast number of patients who will require optometric care.

It is important for optometrists to be familiar with these devices and the rationale behind the device chosen. This article describes what each device is, how they work, complications, and postoperative care.

In a recent filing, Dallas-based gas permeable (GP) contact lens laboratory TruForm Optics has taken legal action against Valeant Pharmaceuticals. The class-action complaint aims to stop competitive behavior, obtain damages for past competitive behavior, and to restore competitive market conditions.

The skyrocketing price of prescription medications has been a huge topic from the presidential campaign trail to social media, thanks in part to former Turing Pharmaceutical CEO and real-life villain Martin Shkreli. Shkreli made headlines in late 2015 when he jacked up the price of Daraprim (pyrimethamine), used to treat toxoplasmosis and malaria, to $750 per pill from $13.50.

I have been fortunate in my career to meet some amazing people: optometrists, ophthalmologists, editors, those involved with industry, and several others along the way. One of the things I enjoy most about the profession is working and collaborating with many to help advance the profession and continue to move it forward.

I always had in my head that I was going to be a doctor. I was specifically in molecular biology, and chemistry was just side gig. So, I had the dream of being an optometrist, got accepted to optometry school and decided it wasn’t for me at the last minute. So, I turned to chemistry, and chemistry was my backup plan.

We’ve already shared our most-read stories for the year, but now it’s our turn to share our favorite stories from 2015-and boy, did we have some fun this year.

In my consulting work with practices, I have found that most of us don’t know if our practice is doing well or not.

Seven months ago, on Friday, May 8, I walked across the stage wearing a graduation gown and hood to receive my fourth and final (for now) degree. It was nearly six years to the day after my graduation from OD school in 2009.

There is a very common misconception that abounds in most clinics regarding safety and who is responsible for clinic/patient safety. Staff often feels that clinic safety is a management problem-not their concern.

When a patient experiencing an ocular emergency walks through the door, it is vital that every member of the team knows what to do in order to save the patient’s sight-and in some cases, his life. (Editor's note: This article contains some graphic images of ocular trauma that may be disturbing to some readers.)

Purchasing a private practice is a big decision and requires thorough preparation. The practice that you purchase can determine where you live and where your children go to school, and it ultimately shapes the lifestyle you’ve been dreaming about your entire life.

my fellow shared with me that after I left the room, the patient complained about me being a “salesman.” Awestruck, I came away realizing that my best intents and clinical knowledge had been taken the wrong way and that the cost of the best treatment for this patient were overshadowed by the fact that she was going to have an out-of-pocket cost.

This is the second in a series of regular legislative updates on new laws that affect optometrists around the country. The laws governing optometrists across the country are constantly evolving, so it can be hard to keep track of who can do what from state to state. New laws in one state can lay the groundwork for similar changes in another.

A common barrier to many practitioners is the concern that their practice does not have the patient foundation to make investment in the services economically profitable. I assure you that OSD management will profit the patient in many ways that includes clearer, more comfortable vision, enhancing their productivity and overall wellbeing.